Meta-analyses involving cross-over trials: methodological issues

被引:1437
作者
Elbourne, DR
Altman, DG
Higgins, JPT
Curtin, F
Worthington, HV
Vail, A
机构
[1] Univ London London Sch Hyg & Trop Med, Med Stat Unit, London WC1E 7HT, England
[2] Imperial Canc Res Fund, Med Stat Grp, Ctr Stat Med, Inst Hlth Sci, Oxford OX3 7LF, England
[3] MRC, Biostat Unit, Inst Publ Hlth, Cambridge CB2 2SR, England
[4] Univ Manchester, Dent Hosp, Manchester M15 6FH, Lancs, England
[5] Hope Hosp, R&D Acad Affairs Directorate, Salford M6 8HD, Lancs, England
关键词
cross-over trials; meta-analysis;
D O I
10.1093/ije/31.1.140
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background Meta-analysis of randomized controlled trials (RCTs) is usually based on trials where patients are randomized individually into two different, parallel, treatment groups. This paper concentrates on RCTs of a different design-two-period, two-treatment cross-over trials. Methods The characteristics of these trials are outlined, with detailed examples of methods for analysis for both continuous and binary data. These case studies are then extended into the context of a meta-analysis. The Cochrane Library was surveyed to assess current practice for synthesis. Results Methods are described for continuous and binary data for use both when the necessary paired data are given and also when they need to be calculated or imputed, and some suggestions are provided to help people wishing to synthesize data from cross-over trials into meta-analyses. The survey suggested that about 8% of the trials in the Cochrane library were cross-over trials and 18% of the reviews referred to such trials, although there was no consistent approach to their inclusion into the reviews. Conclusions Methods do exist for including valuable information from two-period, two-treatment cross-over trials into quantitative reviews. However, poor reporting of cross-over trials will often impede attempts to perform a meta-analysis using the available methods.
引用
收藏
页码:140 / 149
页数:10
相关论文
共 32 条
[1]   Reduction of postprandial hyperglycemia and frequency of hypoglycemia in IDDM patients on insulin-analog treatment [J].
Anderson, JH ;
Brunelle, RL ;
Koivisto, VA ;
Pfutzner, A ;
Trautmann, ME ;
Vignati, L ;
DiMarchi, R ;
Bowen, KM ;
Cameron, DP ;
Nankervis, AJ ;
Roberts, AP ;
Zimmet, P ;
Borkenstein, MH ;
Schernthaner, G ;
Waldhausl, WK ;
DeLeeuw, IH ;
Fery, F ;
Scheen, A ;
Somers, G ;
Fettes, IM ;
Tildesley, HD ;
Toth, EL ;
Viikari, J ;
Altman, JJ ;
Bougneres, PF ;
Drouin, P ;
Fossati, P ;
Guillausseau, PJ ;
Marechaud, E ;
Riou, JP ;
Selam, JL ;
Vialettes, PB ;
Beyer, J ;
Federlin, K ;
Fussganger, RD ;
Gries, FA ;
Jastram, HU ;
Koop, I ;
Landgraf, R ;
Rosak, C ;
Schatz, H ;
SchulzeSchleppinghoff, B ;
Seif, FJ ;
Stoeckmann, F ;
Karasik, A ;
Weitzman, S ;
Andreani, D ;
Bompiani, G ;
Crepaldi, G ;
Giorgino, R .
DIABETES, 1997, 46 (02) :265-270
[2]  
[Anonymous], 2000, STAT CONFIDENCE
[3]  
[Anonymous], STAT CONFIDENCE
[4]   MARGINAL MODELING OF BINARY CROSS-OVER DATA [J].
BECKER, MP ;
BALAGTAS, CC .
BIOMETRICS, 1993, 49 (04) :997-1009
[5]   Meta-analysis of the effect of insulin lispro on severe hypoglycemia in patients with type 1 diabetes [J].
Brunelle, RL ;
Llewelyn, J ;
Anderson, JH ;
Gale, EAM ;
Koivisto, VA .
DIABETES CARE, 1998, 21 (10) :1726-1731
[6]   A review of randomised controlled trials published in Archives of Disease in Childhood from 1982-96 [J].
Campbell, H ;
Surry, SAM ;
Royle, EM .
ARCHIVES OF DISEASE IN CHILDHOOD, 1998, 79 (02) :192-197
[7]  
*COCHR COLL, 2001, COCHR LIB
[8]   Crossover or parallel design in infertility trials? The discussion continues [J].
Cohlen, BJ ;
Velde, ERT ;
Looman, CWN ;
Eijckemans, R ;
Habbema, JDF .
FERTILITY AND STERILITY, 1998, 70 (01) :40-45
[9]  
CURTIN F, 2002, IN PRESS STAT MED
[10]  
Daya S, 1999, FERTIL STERIL, V71, P771